Downstream Processing Innovations in Biologics Production
Downstream processing, the final stage of biologics production, has undergone significant advancements in recent years. Traditionally a bottleneck in the manufacturing process, it is now a focal point for innovation. Advances in chromatography, filtration, and crystallization techniques have streamlined purification steps, increasing yields and reducing costs. Moreover, the integration of automation and process analytical technologies (PAT) has enhanced process control and monitoring. Continuous processing, a departure from batch-wise operations, is gaining traction, promising increased productivity and reduced footprint.
A pivotal area of innovation lies in the development of novel materials and resins for chromatography. These materials offer improved selectivity, capacity, and durability, leading to higher product purity and process efficiency. Additionally, single-use technologies have gained prominence, reducing cleaning validation efforts and accelerating time-to-market. As the demand for biologics continues to rise, the industry is poised for further breakthroughs in downstream processing, ensuring the efficient and cost-effective production of life-saving therapies.
Visit our website to know more: https://www.leadventgrp.com/events/2nd-annual-bioprocessing-and-biologics-forum/details
For more information and group participation, contact us: [email protected]
Leadvent Group - Industry Leading Events for Business Leaders!
www.leadventgrp.com| [email protected]
